Article

PAP 2023: Corey Ford Discusses Part D Requirements at Access PAP 2023

AmerisourceBergen exec dives into the shift in Medicare Part D patient requirements.

In an interview with Pharma Commerce Editor, Nicholas Saraceno, Corey Ford, VP of reimbursement & insight policy, AmerisourceBergen, speaks on the Medicare Part D underinsured patient criteria (when it comes to patient assistance programs) and how it has evolved to more of an impact on patients' functionally uninsured criteria at Access PAP 2023.

Newsletter

Stay ahead in the life sciences industry with Pharmaceutical Commerce, the latest news, trends, and strategies in drug distribution, commercialization, and market access.

Subscribe Now!
Related Videos
Related Content
LEO Pharma to Head Global Commercialization of Spevigo in $105M Deal with Boehringer Ingelheim
July 14th 2025

LEO Pharma to Head Global Commercialization of Spevigo in $105M Deal with Boehringer Ingelheim

Nicholas Saraceno, Editor
The agreement grants LEO Pharma exclusive rights to the branded form of spesolimab for generalized pustular psoriasis and potentially, other IL-36–driven conditions.
How Recent Executive Orders Impact the Drug Pricing Landscape
May 30th 2025

How Recent Executive Orders Impact the Drug Pricing Landscape

Nicholas Saraceno, Editor
Alice Valder Curran outlines the steps manufacturers should take to better prepare for upcoming executive actions on drug pricing and market access.
Reducing Healthcare Prices
July 10th 2025

Reducing Healthcare Prices

Nicholas Saraceno, Editor
In the third part of his Pharma Commerce video interview, Marschall Runge, MD, PhD, dean of the University of Michigan Medical School and author of The Great Healthcare Disruption, proposes ways to ensure both fiscal responsibility and the sustainability of hospital funding.
The Path Forward for Infused Biosimilars in the US
December 18th 2024

The Path Forward for Infused Biosimilars in the US

Nicholas Saraceno, Editor
Vibhu Tewary offers insight on this market segment, including a behind-the-scenes of what goes into designing a report.
Trump Imposes 25% Tariffs on Japan, South Korea, and a Dozen Other Nations
July 8th 2025

Trump Imposes 25% Tariffs on Japan, South Korea, and a Dozen Other Nations

Nicholas Saraceno, Editor
Amid the push for reshoring and fiscal reform, the tariffs are part of a broader effort to rebalance trade and fund domestic initiatives, as the pharma sector awaits potential levies of its own.
How Industry Stakeholders View Medicare Advantage Expansion for Patients with Kidney Disease
July 7th 2025

How Industry Stakeholders View Medicare Advantage Expansion for Patients with Kidney Disease

Nicholas Saraceno, Editor
A qualitative study explores how MA plan leaders, kidney care managers, and dialysis providers perceive the benefits, risks, and marketing practices surrounding MA enrollment for patients with end-stage kidney disease.
© 2025 MJH Life Sciences

All rights reserved.